Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD

Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer

NCT01298362 ·Status: COMPLETED

A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy

NCT02935920 ·Status: COMPLETED ·Phase: NA

Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

NCT05700006 ·Status: COMPLETED

Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment

NCT01144572 ·Status: COMPLETED

Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients

NCT01983995 ·Status: COMPLETED

Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor

NCT01765049 ·Status: ACTIVE_NOT_RECRUITING

Effects of Aromatase Inhibitor Therapy on Muscle Function

NCT03581552 ·Status: COMPLETED

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

NCT00171340 ·Status: COMPLETED ·Phase: PHASE3

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

NCT00003771 ·Status: COMPLETED ·Phase: PHASE3

Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer

NCT06610565 ·Status: RECRUITING ·Phase: NA

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

NCT00171314 ·Status: COMPLETED ·Phase: PHASE3

Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

NCT06781762 ·Status: RECRUITING

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

NCT00516698 ·Status: COMPLETED

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

NCT00859560 ·Status: COMPLETED

Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer

NCT04142476 ·Status: TERMINATED ·Phase: NA

Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life

NCT01030250 ·Status: ACTIVE_NOT_RECRUITING

Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk

NCT05049031 ·Status: COMPLETED ·Phase: NA

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

NCT00556374 ·Status: COMPLETED ·Phase: PHASE3

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

NCT02097459 ·Status: UNKNOWN ·Phase: PHASE3

A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer

NCT07180914 ·Status: NOT_YET_RECRUITING

Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

NCT01831076 ·Status: COMPLETED ·Phase: PHASE2

Breast Cancer Women on Aromatase Inhibitors Treatment

NCT03811509 ·Status: UNKNOWN ·Phase: PHASE4

Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors

NCT03953157 ·Status: COMPLETED ·Phase: NA

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

NCT00963417 ·Status: COMPLETED ·Phase: NA